Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Omicron overpowers key COVID antibody treatments in early tests

Nearly all of the monoclonal antibodies used to prevent severe disease fail to stand up to the new variant, laboratory assays show.
  1. Max Kozlov
    View author publications

    You can also search for this author in PubMed  Google Scholar

Strained hospitals bracing for a COVID-19 surge caused by the quickly spreading Omicron variant could face another grim possibility: preliminary experiments suggest that most of the antibody treatments for the disease are powerless against Omicron1,2,3,4.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-021-03829-0

References

  1. Cameroni, E. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.12.12.472269 (2021).

  2. Aggarwal, A. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.14.21267772 (2021).

  3. Planas, D. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.12.14.472630 (2021).

  4. Cao, Y. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.12.07.470392 (2021).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links